Free Trial

Harvard Bioscience (HBIO) SEC Filings & 10K Form

Harvard Bioscience logo
$0.39 0.00 (-0.51%)
Closing price 04:00 PM Eastern
Extended Trading
$0.41 +0.03 (+6.70%)
As of 05:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Harvard Bioscience SEC Filings

DateFilerForm TypeView
04/10/2025
3:46 PM
Harvard Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2025
8:49 AM
Harvard Bioscience (Subject)
Leviticus Partners LP (Filed by)
Form SCHEDULE 13G/A
03/21/2025
3:49 PM
Green James W (Reporting)
Harvard Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2025
3:50 PM
Cote Jennifer (Reporting)
Harvard Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
9:33 AM
Harvard Bioscience (Subject)
Leviticus Partners LP (Filed by)
Form SCHEDULE 13G
03/12/2025
6:00 AM
Harvard Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/10/2025
3:56 PM
Harvard Bioscience (Subject)
WEBER CAPITAL MANAGEMENT LLC /ADV (Filed by)
Form SCHEDULE 13G
02/04/2025
9:37 AM
Harvard Bioscience (Subject)
Leviticus Partners LP (Filed by)
Form SCHEDULE 13G/A
12/31/2024
3:01 PM
Cote Jennifer (Reporting)
Harvard Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:02 PM
Green James W (Reporting)
Harvard Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2024
11:15 PM
Harvard Bioscience (Filer)
Form EFFECT
12/06/2024
6:45 AM
Harvard Bioscience (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/14/2024
11:31 AM
272 Capital LP (Filed by)
Harvard Bioscience (Subject)
Form SC 13G/A
11/08/2024
3:45 PM
Harvard Bioscience (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2024
6:02 AM
Harvard Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
8:00 AM
Harvard Bioscience (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
7:29 AM
Harvard Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2024
4:01 PM
Harvard Bioscience (Filer)
Form SD
Specialized Disclosure Report  
05/14/2024
4:20 PM
Harvard Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
4:00 PM
Harvard Bioscience (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2024
6:00 AM
Harvard Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:HBIO) was last updated on 4/17/2025 by MarketBeat.com Staff
From Our Partners